[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Bu Aeri] The United States, which began administering the novel coronavirus disease (COVID-19) vaccine to the public, is accelerating additional distribution.


On the 15th (local time), CNBC reported that the U.S. government plans to start vaccinating the public as soon as the vaccine developed by the domestic pharmaceutical company Moderna receives emergency use authorization from the U.S. Food and Drug Administration (FDA).


It also predicted that 6 million doses (a dose refers to one injection) of the Moderna vaccine are expected to receive FDA emergency use approval and begin distribution as early as the 18th.


The FDA advisory committee, the Vaccines and Related Biological Products Advisory Committee (VRBPAC), is scheduled to begin reviewing the Moderna vaccine on the 17th.


Health officials in the U.S. anticipate that the FDA will approve the emergency use of the Moderna vaccine as early as the 18th.


Once the Moderna vaccine receives emergency use authorization, the pharmaceutical distributor McKesson will transport the vaccine to 3,285 distribution centers across the United States.



Gustave Perna, a U.S. Army general and Chief Operating Officer (COO) of the U.S. government's COVID-19 vaccine development program called "Operation Warp Speed," stated that UPS and FedEx will then deliver the vaccines from these centers to vaccination sites.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing